Pediatr. praxi. 2007;8(5):284-287

News in immunization against hvp

doc. MUDr. Roman Prymula CSc., Ph.D
Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové

Immunization against human papillomaviruses is the first vaccination against neoplasma – cervical carcinoma. Vaccine Silgard effective even against genital warts cased by human papillomaviruses typ 6 and 11 has been already registered in the Czech Republic. Competitor´s vaccine Cervarix registration is possible to expect in a very short time. Both vaccines prove their practically 100 % efficacy based on numerous studies and cover more than 70 % of carcinomas of the cervix. Combined with screening vaccination gives assumption of this serious carcinoma effective control worldwide. Vaccine is recommended for the mass immunization in girls aged 12 years and selective immunization of women under 26 years. Boys´ immunization is due to economic reason under discussion up to now.

Keywords: HPV, vaccines, cervical carcinoma

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prymula R, D P. News in immunization against hvp. Pediatr. praxi. 2007;8(5):284-287.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001; 164(7): 1017-1025. Go to PubMed...
    2. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001; 93(4): 315-318. Go to original source... Go to PubMed...
    3. Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 2006; 107(1): 18-27. Go to original source... Go to PubMed...
    4. Markowitz LE. Update: Clinical trials on efficacy of human papillomavirus (HPV) vaccines. CDC. Global vaccine research forum. Bangkok, Thailand, XII. 2006.
    5. Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6): 518-527. Go to original source... Go to PubMed...
    6. Prymula R. Kvadrivalentní vakcína proti lidským papillomavirům. Remedia 2007; 17(1): 114-116.
    7. Richardson H, Kelsall G, Tellier P, Foyer H, Abrahamowicz M, Ferenczy A et al. The natural history of type specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12(6): 485-490.
    8. Stanley M, Lowy DR, Frazer I. Prophylactic HPV vaccines: Underlying mechanisms. Vaccine 2006; 24 (S3): 106-113. Go to original source... Go to PubMed...
    9. Vonka V, Hamšíková E. Vakcína proti lidským papillomavirům: co jí předcházelo, jaká je a co nás čeká v budoucnosti. Vakcinologie. 2007 (1): 6-17.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.